Items where Author is "Agarwal, Arnav"

Article

Lohner, Szimonetta and Gryaznov, Dmitry and von Niederhäusern, Belinda and Speich, Benjamin and Kasenda, Benjamin and Ojeda-Ruiz, Elena and Schandelmaier, Stefan and Mertz, Dominik and Odutayo, Ayodele and Tomonaga, Yuki and Amstutz, Alain and Pauli-Magnus, Christiane and Gloy, Viktoria and Bischoff, Karin and Wollmann, Katharina and Rehner, Laura and Meerpohl, Joerg J. and Nordmann, Alain and Klatte, Katharina and Ghosh, Nilabh and Heravi, Ala Taji and Wong, Jacqueline and Chow, Ngai and Hong, Patrick Jiho and McCord, Kimberly and Sricharoenchai, Sirintip and Busse, Jason W. and Agarwal, Arnav and Saccilotto, Ramon and Schwenkglenks, Matthias and Moffa, Giusi and Hemkens, Lars G. and Hopewell, Sally and von Elm, Erik and Blümle, Anette and Briel, Matthias. (2021) Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional study. Journal of Clinical Epidemiology, 139. pp. 340-349.

Mc Cord, Kimberly A. and Ewald, Hannah and Agarwal, Arnav and Glinz, Dominik and Aghlmandi, Soheila and Ioannidis, John P. A. and Hemkens, Lars G.. (2021) Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study. BMJ, 372. n450.

Ladanie, Aviv and Schmitt, Andreas M. and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Herbrand, Amanda K. and Briel, Matthias and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2020) Clinical trial evidence supporting US Food and Drug Administration approval of novel cancer therapies between 2000 and 2016. Jama Network Open, 3 (11). e2024406.

Schandelmaier, Stefan and Chang, Yaping and Bala, Malgorzata M. and Devasenapathy, Niveditha and Devji, Tahira and Kwong, Joey S. W. and Colunga Lozano, Luis E. and Lee, Yung and Agarwal, Arnav and Bhatnagar, Neera and Ewald, Hannah and Zhang, Ying and Sun, Xin and Thabane, Lehana and Walsh, Michael and Briel, Matthias and Guyatt, Gordon H.. (2020) Erratum to "A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses" [J Clin Epidemiol. 2019;113:159-67]. Journal of Clinical Epidemiology, 123. p. 189.

Janiaud, Perrine and Axfors, Cathrine and Van't Hooft, Janneke and Saccilotto, Ramon and Agarwal, Arnav and Appenzeller-Herzog, Christian and Contopoulos-Ioannidis, Despina G. and Danchev, Valentin and Dirnagl, Ulrich and Ewald, Hannah and Gartlehner, Gerald and Goodman, Steven N. and Haber, Noah A. and Ioannidis, Angeliki Diotima and Ioannidis, John P. A. and Lythgoe, Mark P. and Ma, Wenyan and Macleod, Malcolm and Malički, Mario and Meerpohl, Joerg J. and Min, Yan and Moher, David and Nagavci, Blin and Naudet, Florian and Pauli-Magnus, Christiane and O'Sullivan, Jack W. and Riedel, Nico and Roth, Jan A. and Sauermann, Mandy and Schandelmaier, Stefan and Schmitt, Andreas M. and Speich, Benjamin and Williamson, Paula R. and Hemkens, Lars G.. (2020) The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Research, 9. p. 1193.

Schandelmaier, Stefan and Chang, Yaping and Devasenapathy, Niveditha and Devji, Tahira and Kwong, Joey S. W. and Colunga Lozano, Luis E. and Lee, Yung and Agarwal, Arnav and Bhatnagar, Neera and Ewald, Hannah and Zhang, Ying and Sun, Xin and Thabane, Lehana and Walsh, Michael and Briel, Matthias and Guyatt, Gordon H.. (2019) A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses. Journal of Clinical Epidemiology, 113. pp. 159-167.

Speich, Benjamin and Mc Cord, Kimberly A. and Agarwal, Arnav and Gloy, Viktoria and Gryaznov, Dmitry and Moffa, Giusi and Hopewell, Sally and Briel, Matthias. (2019) Reporting Quality of Journal Abstracts for Surgical Randomized Controlled Trials Before and After the Implementation of the CONSORT Extension for Abstracts. World Journal of Surgery, 43 (10). pp. 2371-2378.

Ladanie, Aviv and Speich, Benjamin and Briel, Matthias and Sclafani, Francesco and Bucher, Heiner C. and Agarwal, Arnav and Ioannidis, John P. A. and Pereira, Tiago V. and Kasenda, Benjamin and Hemkens, Lars G.. (2019) Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies. Journal of clinical epidemiology, 114. pp. 49-59.

Speich, Benjamin and von Niederhäusern, Belinda and Schur, Nadine and Hemkens, Lars G. and Fürst, Thomas and Bhatnagar, Neera and Alturki, Reem and Agarwal, Arnav and Kasenda, Benjamin and Pauli-Magnus, Christiane and Schwenkglenks, Matthias and Briel, Matthias and Making Randomized Trials Affordable Group, . (2018) Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data. Journal of clinical epidemiology, 96. pp. 1-11.

Ladanie, Aviv and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2018) The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: rationale and design of the database and the collection of evidence available at approval of novel drugs. Trials, 19 (1). p. 505.